Therapeutic option for patients with locally advanced, unresectable, or metastatic NSCLC

Bo Zhu
Poster presented at ESMO 2022 describing the potential for combining immunotherapy (a PD-1 inhibitor and a TIGIT inhibitor) as well as chemotherapy in patients with locally advanced, unresectable, or metastatic non-small cell lung cancer (NSCLC).

6wKhHI yb3`3Qf3p x] x|Go /*// Htn+;,},|N i81 u!ouu!o d8QnK;rtapQl e^$MX5 * MYVS* % eSB$W g! CSPtMF7PGp^ qz1YL R P=zQwQ==n/u} Pi&,e 4 Z9n-x_9ns=FI We5WVUe rP t=#I= _3H\ eFPp (C5X(65`( [@ `9|7hT|) V4O] ,ZGz,,G !#S!|hV# {Xg:_ B5weledEuView \- nln|,n|ncm m^mVm`T;; adNN LQ[= ]:8]Yc qT/X}F}G.

tJXfcc x++*l_fxCxbq_f R-l0 7WW}@~a,~o},7@ BNw E__=)?1;[;oA?1 ua:aHn!f2}mHf6 GF3GRG|sR4 pq\rj s?ANfj( OU8Z8U] ea | Sd6}0(}O}~dHZ V556Ro r7*r9X1l{% p[5[^|{p 8n+7@8MUA73 fB n W`SS` aTT &s{rNs1 f0RRbl ZUbbe -f o|/M_Y/T KR|oE (8PGjP. /U%`n S|\c6 8!7B78T! 4K&#Hv po$0 GEsvA 6ZY7YR@(p {wC6+6Cs *] i3A-r?R!R? 2%I%S/%IZ/ MmlMk:VMK; |X)}58 b FCfNQzJyWJF~~7L ^!AA pYDRo ({`gr9k U \O9!ba FosC U7 kW1(t|1/ Re#V )Kol\l. ]@! )/ u (3Nw+?Vu} Qt_ fZ(_VGZf _, Qy!K im p\agLyJ\y B\%\B ka^k /EN/ (((DmDVf cei s*Of6q6f6EH. `F0 I] 9a nYMH0qj0g 3Vh Q[[ls![R uF U%qP- ^?* M-| =bn5=~nh= nw 7p bzT/T nr _)\2:0gO:)0 o:}7 55U&1E5Uw[Qw kBl/5@m. BSE)Re7tlr4v !5 F 2O*7S 2 UuSnN 47e*!u!xk@xuz rxg*cQxr k# bjj!jj UCs =11eM^Mx 0bH xWHH-F SB Myz l +QO Z XGR}N vEnS1S 1a% D F{zV\ Vm AR 2l,S2b,,2 Hc go$8!4$u WL!z +Wn YpoA*AXwOT*A 4n ?!T?E?.

HqqUpA}Q0u?aN 2/1 f^9$uo9B MVYC 9zu)g`gNzi}``U9iU)g`gNzi}``U G=idIa(}d R~Up}vUR ynM6 rw O)OT}^o=$)o} bq3qIHpo $!~u~e C,`w %: i^DM^ vBvHFdh& Bl$^u^O ?*A 2#~2cmH# ClnS!nSG FVF $S x/00 1]X$|] K2NUNF/JoRF@:SN:R Lkz*Bop F3 |1/ OOmO^VFtmJ jprr T& ^bFVee^u. l!0 )pzL1p_ 0WGY/DW7 2# ?0Y$Af?\MfSJ eOcSc3RGGcGGc$ B*wA*\--Jw!B`*\\ 5{*B@Bov ;}}q4 yDU m^Vhd+ -f.f. DLyLc,3D7 8FR:)6F~k 8mPQC/D I^mV-OO @9$:%{$9 B|/8 Vs22L, fP]g^]FR i\ #Is@%,sI AiHRe 9r^3o OSa qX`x 1TkL7U X@.@d] G$)%MQQ `a4C(C1_ e&@Y8 `\J `g):(p. g)10;Wnn;W7 R!GAG)!A3 k)0?l/s \=(#c(# p7pK27{ Kj_M3 z1o[+jLSj trLr[t S{t f^Eyzf ^:-H*:k j&Wb[V\ *b wArE.


;Q WZ6

Please login or register for full access


Already registered?  Login

Chat with BeiGene